Pangolin Therapeutics

Guilford, United States Founded: 2019 • Age: 7 yrs
Provider of drug candidate identifications solutions for drug development

About Pangolin Therapeutics

Pangolin Therapeutics is a Healthcare company based in Guilford (United States) founded in 2019 by Enrique Alvarez Sotomayor and Andrew Miranker. Provider of drug candidate identifications solutions for drug development. Its chief executive, as recorded, is Susan Froshauer. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include NTxBio, Applied BioMath and Nimble Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Pangolin Therapeutics was founded in 2019 and is based in Guilford, United States. Solutions for drug candidate identification in the biotechnology sector are provided through a platform that assists researchers in targeting molecules or toxic protein analogues linked to neurodegenerative and metabolic diseases. Operations focus on advancing drug development processes for these conditions.

  • Headquarters Guilford, United States
  • Founders Enrique Alvarez Sotomayor, Andrew Miranker
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website pangolintherapeutics.com

People of Pangolin Therapeutics

3 people are tracked at Pangolin Therapeutics (3 in leadership).

NameRoleGroup
Enrique Alvarez Sotomayor
Co-FounderLeadership
Andrew Miranker
Co-FounderLeadership
Susan Froshauer
CEOLeadership
Premium access

Complete people profiles for Pangolin Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Pangolin Therapeutics

Pangolin Therapeutics has 3 listed competitors in our database, 3 of them funded. They include NTxBio, Applied BioMath and Nimble Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ntxbio.com2016Santa Fe, United States$74.76M
Provider of bio informatics platform to develops biologics and therapeutics
appliedbiomath.com2013Cambridge, United States$2.32M61
Systems biology and pharmacology modeling services to aid drug discovery and development
nimbletherapeutics.com2019Madison, United States$10M24
Combinatorial chemistry services for peptide-based drug discovery are provided.
Premium access

Detailed competitors of Pangolin Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Pangolin Therapeutics

Websites that share an audience with Pangolin Therapeutics (pangolintherapeutics.com).

Similar websites

Websites whose visitors overlap most with Pangolin Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bioct.org
29%
11K#2,362,632View details

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Pangolin Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pangolin Therapeutics

Pangolin Therapeutics was founded in 2019.

Pangolin Therapeutics is headquartered in Guilford, United States. It is registered at Guilford, Connecticut, United States.

Susan Froshauer is the CEO of Pangolin Therapeutics, as recorded in our data.

Pangolin Therapeutics was founded in 2019 and is based in Guilford, United States. Solutions for drug candidate identification in the biotechnology sector are provided through a platform that assists researchers in targeting molecules or toxic protein analogues linked to neurodegenerative and metabolic diseases. Operations focus on advancing drug development processes for these conditions.

Pangolin Therapeutics's top competitors include NTxBio, Nimble Therapeutics and Applied BioMath.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available